Retatrutide is a newly discovered molecule that shows promise as a treatment for type 2 diabetes. It functions as a stimulator of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating blood sugar levels. By imitating the effects of GLP-1, Retatrutide can enhance insulin secretion from the pancreas and limit glucago

The burgeoning landscape of novel treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a similar therapeutic goal – improving glycemic control and promoting significant weight decrease – they exhibit intriguing variations in their pharm